Kirin (KNBWY)
(Delayed Data from OTC)
$12.95 USD
+0.08 (0.65%)
Updated Jul 3, 2024 12:59 PM ET
1-Strong Buy of 5 1
C Value A Growth B Momentum A VGM
Price, Consensus and EPS Surprise
KNBWY 12.95 +0.08(0.65%)
Will KNBWY be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for KNBWY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for KNBWY
Best Growth Stocks to Buy for July 2nd
Best Income Stocks to Buy for July 2nd
KNBWY: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for June 28th
New Strong Buy Stocks for June 26th
KNBWY or SAM: Which Is the Better Value Stock Right Now?
Other News for KNBWY
Hold Rating on Kirin Holdings Amid Growth and Caution in Health-Centric Strategy
Kirin Holdings Commences Tender Offer To Make FANCL A Wholly-Owned Subsidiary
Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC
Kirin Holdings will begin online sales of "Electric Salt Spoon", a spoon that uses electricity to enhance salty and umami taste*1, on May 20
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and Ophthalmology Annual Meeting 2024